The American Journal of Cardiology
One drug class linked to fewer events in obesity with inflammation
Glucagon-like peptide-1 receptor agonists were linked to a lower combined hazard of death, heart attack or stroke than comparator drugs, with a hazard ratio of 0.799.Glucagon-like peptide-1 receptor agonists were linked to a lower combined hazard of death, heart attack or stroke than comparator drugs, with a hazard ratio of 0.799.

Cohort studyObesity
Who was studiedAdults with obesity and elevated CRP, up to 3,650 days
What changedCombined death, heart attack, or stroke risk was lower with glucagon-like peptide-1 receptor agonists than comparator drugs (hazard ratio 0.799)
The catchWeight and inflammation changes during follow-up were not measured







![Classification of obesity.[38] BMI: Body mass index](/_next/image?url=%2Ffig%2FMED-42683980%2Ff5fa9110.webp&w=1600&q=75&dpl=e0fc17f515e1)